Centogene NV is a commercial-stage company, which focuses on rare diseases that transform real-world clinical and genetic data into actionable information for patients, physicians, and pharmaceutical companies. The company is headquartered in Rostock, Mecklenburg-Vorpommern and currently employs 493 full-time employees. The company went IPO on 2019-11-07. The firm focuses on rare diseases, transforming clinical and genetic data into actionable information for patients, physicians and pharmaceutical companies. The firm's platform includes epidemiological, phenotypic, and genetic data reflecting a global population, as well as a biobank of blood samples from these patients. The firm's pharmaceutical segment provides a variety of services to its pharmaceutical partners, including early patient recruitment and identification, epidemiological insights, biomarker discovery, and patient monitoring. The firm's Clinical Diagnostics segment provides targeted genetic sequencing and diagnostic services to patients through its distribution partners and customers, which are typically physicians, laboratories or hospitals.
Principales calificaciones de analistas para CNTGF
Basado en 9 analistas que dan calificaciones de acciones a CNTGF, actualizado el Nov 01, 2024
Strong Buy
Strong buy
3
Buy
5
Hold
1
Sell
0
Strong sell
0
Leveraging in-depth analyst evaluations, we have synthesized critical insights from expert assessments to deliver a robust outlook for CNTGF. Our analysts highlight strong fundamentals and favorable market sentiment, positioning CNTGF for significant upside potential in the near term. Based on this comprehensive expert analysis, we maintain a highly optimistic view of this stock. Our conclusion: CNTGF is a Strong Buy candidate.
CNTGF stock price ended at $0.11 on Jueves, after rising 0.00%
On the latest trading day Feb 05, 2026, the stock price of CNTGF rose by 0.00%, climbing from $0.11 to $0.11. Throughout the session, the stock experienced a volatility of 0.00%, with prices fluctuating between a daily low of $0.11 and a high of $0.11. Alongside this price increase, trading volume also rose by 26.2K shares, reflecting strong market interest that may signal continued bullish momentum in the near term. In total, 12.9K shares were traded, amounting to a market value of approximately $3.0M.
Señales Técnicas de CNTGF
Resumen de Señales Técnicas
Señales de compra 4
Señales Neutras 1
Señales de venta 2
Strong Sell
Sell
Neutral
Buy
Strong Buy
CNTGF actualmente presenta 4 señales de compra y 2 señales de venta. La acción ha estado en una tendencia alcista desde 12:00 AM, con un cambio total en el precio de -- durante este período. En general, los indicadores técnicos apuntan a una perspectiva Buy para el mediano plazo.
Señales alcistas/bajistas para CNTGF
Analizamos indicadores clave como medias móviles, RSI, MACD y volumen de negociación para generar señales alcistas y bajistas para CNTGF. Estas perspectivas te ayudan a tomar decisiones de inversión más informadas.
Preguntas de seguimiento
¿Cómo se aplican los indicadores de análisis técnico a CNTGF?
¿Cuáles son los niveles de retroceso de Fibonacci para CNTGF?
¿Cuál es el RSI de Crown LiquidationCo NV in liquidatie?
¿Cuál es el precio de Crown LiquidationCo NV in liquidatie para los próximos 12 meses?
¿Hasta dónde se espera que suba Crown LiquidationCo NV in liquidatie?